FDA Inspection 835225 — Towa Pharmaceutical Europe, S.L.

Towa Pharmaceutical Europe, S.L. — FEI 3003121577

The FDA completed an inspection of Towa Pharmaceutical Europe, S.L. on May 10, 2013 in Martorelles. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 10, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Martorelles (Spain)